Utama › Kanser Prostat › South Carolina › Myrtle Beach
Kajian klinikal Kanser Prostat di Myrtle Beach, SC
24 kajian untuk Kanser Prostat sedang mencari peserta di lokasi dalam dan sekitar Myrtle Beach (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
Mengambil pesertaFasa 3
- Carolina Urologic Research Center, Myrtle Beach
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- MUSC Hematology-Oncology at Murrells Inlet, Murrells Inlet · 13 mi jauh
Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
Mengambil pesertaKajian pemerhatian
- Carolina Urologic Research Center, Myrtle Beach
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
Mengambil pesertaFasa 1
- Carolina Urologic Research Center, Myrtle Beach
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Mengambil pesertaFasa 1/2
- Carolina Urologic Research Center, Myrtle Beach
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Mengambil pesertaFasa 1/2
- Research Site, Myrtle Beach
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Mengambil pesertaFasa 3
- Grand Strand Medical Center, Myrtle Beach
- Carolina Urologic Research Center, LLC, Myrtle Beach
- Parkway Surgery Center, Myrtle Beach
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
Mengambil pesertaFasa 1
- START Carolinas, Myrtle Beach
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Mengambil pesertaFasa 2/3
- Carolina Urologic Research Center, Myrtle Beach
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Mengambil pesertaFasa 3
- South Texas Accelerated Research Therapeutics - Carolinas, Myrtle Beach
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Mengambil pesertaFasa 3
- Carolina Urologic Research Center, Myrtle Beach
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Mengambil pesertaFasa 3
- Research Site, Myrtle Beach
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Mengambil pesertaFasa 2
- START Carolinas, Myrtle Beach
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Mengambil pesertaFasa 3
- Carolina Urologic Research Center, Myrtle Beach
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Mengambil pesertaFasa 2
- Carolina Urologic Research Center, Myrtle Beach
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Mengambil pesertaFasa 3
- Research Site, Myrtle Beach
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Mengambil pesertaFasa 2
- Carolina Urologic Research Center, Myrtle Beach
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
Mengambil pesertaFasa 1
- Carolina Urologic Research Center, Myrtle Beach
PSMA PET Combined With MRI for the Detection of PCa
Mengambil pesertaFasa 3Sukarelawan sihat dialu-alukan
- Atlantic Urology Specialists, Myrtle Beach
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Mengambil pesertaFasa 1
- Carolina Urologic Research Center, the START Center for Cancer Research, Myrtle Beach
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
Mengambil pesertaFasa 1
- South Texas Accelerated Research Therapeutics - Carolinas, Myrtle Beach
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Mengambil pesertaFasa 1
- Carolina Urologic Research Center, Myrtle Beach
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Mengambil pesertaFasa 3
- Carolina Regional Cancer Center, Myrtle Beach
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
Mengambil pesertaFasa 2
- Carolina Urologic Research Center, Myrtle Beach
Kajian Kanser Prostat di bandar lain
- New York City, NY103 kajian
- Houston, TX76 kajian
- Los Angeles, CA61 kajian
- Boston, MA59 kajian
- St. Louis, MO46 kajian
- Chicago, IL45 kajian
- San Francisco, CA45 kajian
- Philadelphia, PA44 kajian
- Baltimore, MD43 kajian
- Nashville, TN43 kajian
- Seattle, WA42 kajian
- Washington, DC38 kajian
Kajian lain di Myrtle Beach
- Kanser Pundi Kencing10 kajian
- Kanser Pundi Kencing Bukan Invasif Otot9 kajian
- Kanser Ginjal (Karsinoma Sel Renal)6 kajian
- Karsinoma Urotelial (Sel Transisi)5 kajian
- Kanser Metastatik5 kajian
- Diabetes Jenis 23 kajian
- Kanser Prostat Rintangan Kastra3 kajian
- Kanser (semua jenis)3 kajian
- Karsinoma In Situ3 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.